| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
APOA5 Lentiviral Vector (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
| Short name: |
APOA5 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus-Red Fluorescent-2A-Puro), apolipoprotein A-V Lentiviral integrating Desoxyribonucleic acid sequence (H |
| Alternative to gene target: |
APOA5 and IDBG-630769 and ENSBTAG00000019764 and 538914, APOA5 and IDBG-72432 and ENSG00000110243 and 116519, Apoa5 and IDBG-161348 and ENSMUSG00000032079 and 66113, Extracellular, lipoprotein particle receptor binding, this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0006641 and triglyceride metabolic process and biological process this GO :0006869 and lipid transport and biological process this GO :0008047 and enzyme activator activity and molecular function this GO :0008201 and heparin binding and molecular function this GO :0008289 and lipid binding and molecular function this GO :0009725 and response to hormone and biological process this GO :0010898 and positive regulation of triglyceride catabolic process and biological process this GO :0010902 and positive regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0019433 and triglyceride catabolic process and biological process this GO :0019899 and enzyme binding and molecular function this GO :0031100 and organ regeneration and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0035473 and lipase binding and molecular function this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042246 and tissue regeneration and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045723 and positive regulation of fatty acid biosynthetic process and biological process this GO :0048260 and positive regulation of receptor-mediated endocytosis and biological process this GO :0050750 and low-density lipoprotein particle receptor binding and molecular function this GO :0050996 and positive regulation of lipid catabolic process and biological process this GO :0051006 and positive regulation of lipoprotein lipase activity and biological process this GO :0055090 and acylglycerol homeostasis and biological process this GO :0060229 and lipase activator activity and molecular function this GO :0060230 and lipoprotein lipase activator activity and molecular function this GO :0070325 and lipoprotein particle receptor binding and molecular function this GO :0070328 and triglyceride homeostasis and biological process, this GO :0005543 : phospholipid binding, this GO :0005543 : phospholipid binding and also this GO :0008047 : enzyme activator activity and also this GO :0008201 : heparin binding and also this GO :0008289 : lipid binding and also this GO :0019899 : enzyme binding and also this GO :0031210 : phosphatidylcholine binding and also this GO :0035473 : lipase binding and also this GO :0050750 : low-density lipoprotein particle receptor binding and also this GO :0060229 : lipase activator activity and also this GO :0060230 : lipoprotein lipase activator activity and also this GO :0070325 : lipoprotein particle receptor binding, this GO :0008047 : enzyme activator activity, this GO :0008201 : heparin binding, this GO :0008289 : lipid binding, this GO :0019899 : enzyme binding, this GO :0031210 : phosphatidylcholine binding, this GO :0035473 : lipase binding, this GO :0050750 : low-density lipoprotein particle receptor binding, this GO :0060229 : lipase activator activity, this GO :0060230 : lipoprotein lipase activator activity, this GO :0070325 : lipoprotein particle receptor binding, apolipoprotein A-V |
| Identity: |
17288 |
| Gene: |
APOA5 |
More about : APOA5 |
| Long gene name: |
apolipoprotein A5 |
| Synonyms gene name: |
apolipoprotein A-V |
| Synonyms: |
RAP3 APOA-V |
| Locus: |
11q23, 3 |
| Discovery year: |
2001-12-11 |
| GenBank acession: |
AF202889 |
| Entrez gene record: |
116519 |
| Pubmed identfication: |
11588264 11577099 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000046116 |